Does area-level socioeconomic deprivation impact post-PCI outcomes stratified by P2Y12 inhibitor therapy?
Higher socioeconomic deprivation is associated with worse ischemic outcomes with clopidogrel and worse bleeding outcomes with alternative P2Y12 inhibitors after PCI.
Higher SDI was associated with an increased risk of MAE with clopidogrel and bleeding with alternative therapy following PCI. Whether addressing socioeconomic disparities improves P2Y12 inhibitor-related outcomes remains to be determined.
Malavé et al. (Tue,) studied this question.